News

The next revolutionary medical breakthrough could happen on home soil following a $31 million boost into University of Queensland-led health research projects.

University of Queensland Ochsner medical graduate, Dr Elise Roche Venable is among 40 high-achieving pathologists, pathology residents, and medical laboratory professionals under age 40 who have just been named to the prestigious 2019 ASCP 40 Under Forty list.

Asking the age-old question ‘is it a bacteria or is it a virus?’ is what doctors often consider when treating patients with an upper respiratory tract infection (URTI).

A new era of personalised treatment is on the horizon for patients diagnosed with non-Hodgkin's lymphoma, scoring another huge win in the fight against blood cancer.

Leonardo Seoane, MD, FACP, has been named Associate Vice Chancellor of Academic Affairs at LSU Health Shreveport.

Ochsner has partnered with Cleveland Clinic’s Cardiothoracic Collaborative Clinical Center for participation in the Cardiothoracic Surgical Trials Network (CTSN). Dr. Gene Parrino, Section Head of Thoracic and Cardiovascular Surgery at Ochsner, is the Ochsner Principal Investigator for the study.

Scientists from The University of Queensland’s Diamantina Institute have revealed the difference between a stem cell and other blood vessel cells using gene-sequencing technology.

Families with a high prevalence of breast cancer may soon know more about why they are at a greater risk of developing the disease.

Congratulations to Professor Ranjeny Thomas, who has been awarded the Royal Australasian College of Physicians (RACP) Eric Susman Prize for 2018.

The University of Queensland’s best and brightest were recognised at the Faculty of Medicine Prizes and Scholarships awards, Tuesday evening (16 April).

The presence of different strains of grass pollen in the atmosphere can help predict when hay fever and asthma could strike, a study involving a University of Queensland researcher has found.

The University of Queensland has ranked above world standard in major health and medical science categories.

Medical students from UQ-Ochsner Clinical School, in partnership with their cohorts at LSU School of Medicine and Tulane University School of Medicine, were recipients of grant funding from the 2018 Society of General Internal Medicine (SGIM) “Proud to be GIM” campaign. They were among 20 institutional recipients of the award and received matching funding from Ochsner, LSU, and Tulane.

Medical graduates of The University of Queensland Ochsner Doctor of Medicine Program celebrated 2019 Match Day with a 93% Match Rate which marks the seventh year in a row that the program’s Match Rate has been 90% or above.

Ochsner Academics is pleased to announce that Christopher Van Hise is the inaugural recipient of the Dr. and Mrs. Roy Gregory Scholarship for Family Medicine.

The University of Queensland will investigate the potential of existing drugs to be repurposed to fight Parkinson’s disease thanks to a new research grant.

University of Queensland researchers have discovered a hidden metabolic advantage that prevents people with a specific type of dwarfism from developing type 2 diabetes or cancer.

Three clinical trials for rare cancer treatments and a dialysis education program led by University of Queensland researchers have been awarded more than $7.6 million in grants.